Evidence map›Paper›PMID 33540617›Full record

ArticleInternational journal of molecular sciences2021

ERK-Directed Phosphorylation of mGlu5 Gates Methamphetamine Reward and Reinforcement in Mouse.

Elissa K Fultz, Sema G Quadir, Douglas Martin, Daniel M Flaherty, Paul F Worley, Tod E Kippin, Karen K Szumlinski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Effects of positive mGlu5 modulation on DJournal of psychopharmacology (Oxford, England) · 2025
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Elissa K FultzDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Sema G QuadirDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.ORCID 0000-0003-4413-9920
Douglas MartinDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Daniel M FlahertyDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
Paul F WorleyDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Tod E KippinDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.ORCID 0000-0003-3216-8863
Karen K SzumlinskiDepartment of Psychological and Brain Sciences, University of California Santa Barbara, Santa Barbara, CA 93106, USA.ORCID 0000-0003-1078-1077
University of California, Santa Barbara · USJohns Hopkins University · US

Funding

ANALYSIS OF A NOVEL COCAINE INDUCED IMMEDIATE EARLY GENER37DA010309 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WORLEY, PAUL F · 2005 to 2013
$5.5M
NOVEL COCAINE-INDUCED IEGR01DA010309 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WORLEY, PAUL F · 1996 to 2019
$3.6M
Molecular regulation of CeA glutamate and binge drinkingR01AA016650 · NIAAA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SZUMLINSKI, KAREN KATHLEEN · 2010 to 2014
$1.7M
mGluR-Homer interactions in excessive drinkingU01AA016650 · NIAAA · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SZUMLINSKI, KAREN KATHLEEN · 2006 to 2008
$475k
NIAAA NIH HHS AA016650NIAAA NIH HHS R01 AA016650NIDA NIH HHS DA10309University of California, Santa Barbara Faculty Research Assistance AwardUniversity of California, Santa Barbara Undergraduate Research and Creative Activities Award
6 · The paper itself

Abstract

Methamphetamine (MA) is a highly addictive psychomotor stimulant drug. In recent years, MA use has increased exponentially on a global scale, with the number of MA-involved deaths reaching epidemic proportions. There is no approved pharmacotherapy for treating MA use disorder, and we know relatively little regarding the neurobiological determinants of vulnerability to this disease. Extracellular signal-regulated kinase (ERK) is an important signaling molecule implicated in the long-lasting neuroadaptations purported to underlie the development of substance use disorders, but the role for this kinase in the propensity to develop addiction, particularly MA use disorder, is uncharacterized. In a previous MA-induced place-conditioning study of C57BL/6J mice, we characterized mice as MA-preferring, -neutral, or -avoiding and collected tissue from the medial prefrontal cortex (mPFC). Using immunoblotting, we determined that elevated phosphorylated ERK expression within the medial prefrontal cortex (mPFC) is a biochemical correlate of the affective valence of MA in a population of C57BL/6J mice. We confirmed the functional relevance for mPFC ERK activation for MA-induced place-preference via site-directed infusion of the MEK inhibitor U0126. By contrast, ERK inhibition did not have any effect upon MA-induced locomotion or its sensitization upon repeated MA treatment. Through studies of transgenic mice with alanine point mutations on T1123/S1126 of mGlu5 that disrupt ERK-dependent phosphorylation of the receptor, we discovered that ERK-dependent mGlu5 phosphorylation normally suppresses MA-induced conditioned place-preference (MA-CPP), but is necessary for this drug's reinforcing properties. If relevant to humans, the present results implicate individual differences in the capacity of MA-associated cues/contexts to hyper-activate ERK signaling within mPFC in MA Use Disorder vulnerability and pose mGlu5 as one ERK-directed target contributing to the propensity to seek out and take MA.

Indexed as

AnimalsCentral Nervous System StimulantsExtracellular Signal-Regulated MAP KinasesMaleMethamphetamineMiceMice, Inbred C57BLNarcotic-Related DisordersPhosphorylationPrefrontal CortexProtein Processing, Post-TranslationalReceptor, Metabotropic Glutamate 5Reinforcement, PsychologyRewardCentral Nervous System StimulantsExtracellular Signal-Regulated MAP KinasesMethamphetamineReceptor, Metabotropic Glutamate 5addictionmetabotropic glutamate receptor 5methamphetamineplace-conditioningreinforcementself-administrationvulnerability

Identifiers

PMID33540617
PMCPMC7867251
OpenAlexW3126790280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.